Simplify Asset Management’s Kalaris Therapeutics KLRS Stock Holding History

Simplify Asset Management’s Portfolio KLRS Stock Details KLRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-87,426	Closed	-$504K	–	162
2026 Q1	$504K	Buy	87,426 +67,352	+336%	+$598K	0.01%	104
2025 Q4	$169K	Buy	+20,074	New	+$128K	﹤0.01%	138

Simplify Asset Management's KLRS Position: Q2 2026 in Review

Simplify Asset Management sold out of Kalaris Therapeutics (KLRS) in Q2 2026, closing a stake of 87,426 shares — an estimated $504K sold.

Simplify Asset Management first reported a position in KLRS in Q4 2025 and held it in 2 quarters. The position peaked at $504K in Q1 2026. 0 funds tracked by Wall St. Rank hold KLRS as of Q2 2026.

Simplify Asset Management reported no remaining Kalaris Therapeutics position as of Q2 2026 after selling out during the quarter.
Simplify Asset Management sold 87,426 Kalaris Therapeutics shares in Q2 2026, an estimated $504K.
Simplify Asset Management first reported a position in Kalaris Therapeutics in Q4 2025 and held it in 2 quarters.
Simplify Asset Management's Kalaris Therapeutics position peaked at $504K in Q1 2026.
0 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.